₹-1.03
(Market cap
₹14 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
129.3
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-13 Cr
-
ROE
-103.7 %
-
ROCE
-10.9 %
-
Industry P/E
39.7
-
EV/EBITDA
71.1
-
Debt to Equity
6.7
-
Book Value
₹16.5
-
EPS
₹-7.6
-
Face value
10
-
Shares outstanding
7,112,000
9 Years Aggregate
CFO
₹6.19 Cr
EBITDA
₹10.75 Cr
Net Profit
₹-30.02 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vanta Bioscience
| -16.4 | -22.3 | 26.1 | -24.9 | -- | -32.0 | -- |
|
BSE Healthcare*
| 18.4 | 1.4 | 9.8 | 17.9 | 22.6 | 14.4 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vanta Bioscience
| -44.3 | -21.0 | -15.9 | -49.8 | -3.2 | 17.2 | 33.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vanta Bioscience
|
19.6 | 14.0 | 2.0 | -13.3 | -- | -103.7 | 129.3 | 1.0 |
| 3,217.1 | 26,448.1 | 1,461.8 | 387.4 | 34.5 | 25.2 | 68.5 | 15.3 | |
| 833.9 | 16,377.6 | 7,784.0 | 688.5 | 10.6 | 14 | 23.6 | 2.8 | |
| 455.6 | 17,450.3 | 2,141.5 | 58.5 | 5.8 | 3.3 | 164.3 | 4.5 | |
| 828.9 | 20,567.1 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.1 | 4.2 | |
| 1,527.2 | 17,434.9 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 213.8 | 28,537.5 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,833.7 | 30,302.3 | 1,935.8 | 288.2 | 20.6 | 29.8 | 105.1 | 22.6 | |
| 400.0 | 16,219.4 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.4 | 3.4 | |
| 1,889.0 | 30,857.3 | 3,564.0 | 414.0 | 15.3 | 8.4 | 75.4 | 6.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vanta Bioscience
Research and experimental development on natural sciences and engineering
-
Incorporated
2016
-
Chairman
--
-
Managing Director
Dopesh Raja Mulakala
-
Headquarters
Secunderabad, Telangana
-
Website
Looking for more details about Vanta Bioscience Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Vanta Bioscience
What is the current share price of Vanta Bioscience Ltd Today?
The share price of Vanta Bioscience Ltd is ₹19.64 (BSE) as of 13-Aug-2026 IST. Vanta Bioscience Ltd has given a return of -24.89% in the last 1 years.
What is the current PB & PE ratio of Vanta Bioscience Ltd?
The P/E ratio of Vanta Bioscience Ltd is 129.33 times as on 13-Aug-2026, a 226 premium to its peers’ median range of 39.70 times.
The P/B ratio of Vanta Bioscience Ltd is 0.97 times as on 13-Aug-2026, a 74 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
1.34 |
2024 |
0.00 |
2.66 |
2023 |
0.00 |
2.07 |
2022 |
786.33 |
2.89 |
2021 |
228.87 |
4.30 |
What is the 52 Week High and Low of Vanta Bioscience Ltd?
The 52-week high and low of Vanta Bioscience Ltd are Rs 29.00 and Rs 14.71 as of 31-Aug-2026.
What is the market cap of Vanta Bioscience Ltd?
Vanta Bioscience Ltd has a market capitalisation of ₹ 14 Cr as on 13-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vanta Bioscience Ltd?
Before investing in Vanta Bioscience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.